CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what

Size: px
Start display at page:

Download "CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what"

Transcription

1 Cardiac surgery induced acute kidney injury and the perfusionist M. Ranucci Director of Clinical Research Dept of Cardiothoracic and Vascular Anesthesia and Intensive Care IRCCS Policlinico S.Donato Ranuuci, M et al Outline CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what (probably) bl can do

2 Outline CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what (probably) bl can do Things we really, honestly know about AKI after cardiac surgery It happens! Recurrent clinical observation Multiple (>200) human case series, case reports and epidemiological papers It severely deteriorates the outcome Courtesy of R. Belloma

3 Things we really, honestly know about AKI after cardiac surgery As many as 50% of the patients who require new-onset RRT early after cardiac surgery will die CSI-AKI may irreversibly deteriorate kidney function Even small rises in serum creatinine are associated with a worse outcome RIFLE criteria The definition of AKI AKIN criteria Should be applied within 48 hours from surgery

4 Things we really know about ARF after cardiac surgery It is the second most common type of severe ARF in Australian ICUs Estimate:1/100,000/year 20 (10,000 in developed countries) % 5 0 Sepsis Cardiac Sx Cardiac shock AAA Sx Silvester W, Bellomo R, Cole L. Crit Care Med 2001; 29: Courtesy of R. Belloma Risk RIFLE Criteria for Acute Renal Dysfunction GFR Criteria* Urine Output Criteria Abrupt (1-7 days) Increase creat 50% or GFR decrease > 25% UO <.5ml/kg/h x 3 hr High Sensitivity Injury Increase creat x2 Or GFR decrease > 50% UO <.5ml/kg/h x 12 hr Failure Increase creat x3 Or GFR decrease > 75% UO <.3ml/kg/h x 24 hr Anuria x 12 hrs High Specificity Loss ESRD Courtesy of R. Belloma Persistent ARF** = complete loss of renal function > 2 weeks End Stage Renal Disease Bellomo et al. Critical Care 2004; 8: R

5 AKIN Criteria for Acute Renal Dysfunction AKI stage 1: serum creatinine increase +50% x baseline AKI stage 2: serum creatinine increase 2 x baseline AKI stage 3: serum creatinine ne increase 3 x baseline or RRT

6 What do we mean by AKI? Typically we actually only measure very few aspects of renal function By AKI we actually clinically mean loss of small solute clearance (urea/creatinine) This implies loss of GFR (GFR could be preserved but there might be solute backleak) So..clinically we actually mean probable acute decrease in GFR Courtesy of R. Belloma What happens with cardiac surgery which might decrease GFR? Low cardiac output Low BP Pulsatility is lost Major biological changes with CPB Hemolysis Hemodilution (too little/too much) Other factors Courtesy of R. Belloma

7 Circumstantial evidence Low cardiac output syndrome (LCOS) is typically associated with ARF Makes physiological sense (decreased blood flow to kidneys and glomeruli) Other states of LCOS (AMI, cardiac arrest, CCF) also lead to ARF Ischemia (decreased flow to glomeruli) seems a resonable explanation Courtesy of R. Belloma Perfusion Pressure and Organ Flow RPP = MAP - Tissue pressure CPP = DAP - LVEDP % Blood flow Kidney Heart Hypertrophic heart Renovascular disease Courtesy of R. Belloma MAP in mmhg

8 Outline CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what (probably) bl can do Predicting AKI after Cardiac Surgery Need to define AKI first Variable definitions iti in the literaturet If AKI = need for renal replacement therapy (clinically relevant) - incidence: 2-5% If >50% decrease in GFR (still clinically relevant) using formulae- then 4-8% If lesser changes variable incidence but unclear clinical relevance Courtesy of R. Belloma

9 Risk Factors on MVLRA 4 OR 3,5 3 2,5 2 1,5 1 0,5 0 Age (y) Sex Preop Creat (mg/dl) Preop IABP Complex Sx Emergency Sx Left main PVD n=24,660 from Cleveland Clinic (Am J Kidney Dis 2003) Courtesy of R. Belloma Predicting ARF Recursive partitioning algorithm (Kidney Int 2000) If Creat Cl <60 ml/min, IABP, LVEF<35%, PVD, valve Sx = 7.1% incidence of dialysis If Cr Cl >60 ml/min, no previous heart Sx, no valve = 0.7% incidence of dialysis Courtesy of R. Belloma

10 The biggest risk factor: CRF 35 3,5 % risk of ARF 3 2,5 2 1,5 1 0,5 0 Courtesy of R. Belloma > <40 Estimated creatinine clearance in ml/min Odds Ratios for ARF Cr Cl<40 Cr Cl Cr Cl IABP preop EF<35% 1 0 Fortescue et al. Kidney Int 2000; 57: Courtesy of R. Belloma

11 Other independent predictors of need for RRT diabetes cardiogenic shock urgent Sx NYHA 3 or 4 CPB > 2 hours LCOS Need for post op transfusion Courtesy of R. Belloma Limitations Most data from single centres No standard criteria for RRT No agreed definition of ARF No multinational database Limited information on area under the curve for ROC Limited information on calibration Courtesy of R. Belloma

12 Clinical Score from Cleveland Clinic n=15,838 to develop it and n=>17,000 to validate it One point each for: female, CHF, LVEF<35%, COPD, IDDM, Re-do Sx, Valve only Sx. Two points each for: Pre-op IABP, Emergency Sx, CABG+valve, Other Sx, Creat 1.2 to <2.1mg/dL Five points if creat 2.1 mg/dl Courtesy of R. Belloma Am J Kidney Dis Cleveland Score AUC for ROC = % needing dialysis Development cohort Validation cohort 5 Courtesy of R. Belloma 0 0 to 2 3 to 5 6 to 8 9 to 13 Score

13

14

15

16

17 Outline CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what (probably) bl can do Possible perfusion-related risk factors CPB itself Perfusion pressure Perfusion flow Loss of pulsatility Severe hemodilution Poor oxygen delivery Hemolysis

18

19

20 2 Audience Response Questions

21

22

23 Pressure on CPB may be important Flow on CPB is extremely important

24

25 Audience Response Question

26

27 Inappropriate transfusions induce AKI!!!!

28 Possible perfusion-related risk factors CPB itself Perfusion pressure Perfusion flow Loss of pulsatility Severe hemodilution Poor oxygen delivery Hemolysis The Renal Corpuscle Composed of Glomerulus and Bowman s capsule

29 STRUCTURE OF THE KIDNEY(after A.Despopoulos & S.Silbernagl, Color Atlas of Physiology, 2003) Vesa Recta

30

31

32 Kidney and oxygen supply Renal medulla is chronically hypoxemic A low oxygen content (hemodilution) further worsen kidney hypoxia Low blood flow is a major determinant of reduced d oxygen supply : A CHANGE IN PARADYGM

33

34

35 % < > 28 Total N/100 Lowest HCT on CPB % ARF-D Cut off Karkouti et al, Ann Thorac Surg te (%) Mortality rat < > 24 MEN WOMEN Lowest HCT on CPB DeFOE et al, Ann Thorac Surg 2001

36 Habib et al, JTCVS 2003 Lowest HCT on CPB is associated to: Reopening Bleeding Perioperative MI Cardiac arrest Stroke Coma Prolonged ventilation IABP Renal failure MOF

37 RBC transfusion rate CRUDE RBC transfusion rate ADJUSTED 2 2 RBCunitstransfusionrate transfusion rate CRUDE 2 RBC units transfusion rate ADJUSTED AKI rate CRUDE AKI rate ADJUSTED FAVOURS LPVO Inspire FAVOURS CONVENTIONAL Figure Nadir HCT 24% AKI rate (% with 95 % CI) Conventional: 15% P < 0.05 Inspire: 9.7% Nadir HCT on CPB (%)

38 0.25 Nadir HCT 24% AKI rate (% with 95 % CI) Conventional: 15% 20 years later Data confirmed! P < 0.05 Inspire: 9.7% Nadir HCT on CPB (%) Audience Response Question

39 Why severe hemodilution on CPB is so bad? Viscosity, cp; OD DI Oxygen Delivery Index vs.viscosity Hematocrit, % Viscosity ODI

40 Running CPB below the critical DO2 means pushing the patient into the anaerobic zone a bad place to stay

41 AUC: 0.76 AUC: 0.73 nal failure rate (%) p < 0.01 p < % 6.2 % Low hematocrit n = 242 Rena al replacement -Acute re % High hematocrit n = 640 A 1.9 % Low hematocrit n = 53 B High hematocrit n = 113 High oxygen delivery Low oxygen delivery Group If we increase the pump flow and restore an adequate DO2,the ARF rate stays low; conversely, a low DO2 is associated to a high ARF even in presence of a high HCT C D

42 THE GOAL-DIRECTED PERFUSION CONCEPT 3,0 ak Arterial Blood Lactate (mmol/l) Pea 2,5 2,0 1,5 Critical DO2 GDP: KEEP THE PATIENT HERE 1, Lowest Oxygen Delivery (ml/min/mq)

43 nal failure rate (%) p < 0.01 p < % 6.2 % Low hematocrit n = 242 Rena al replacement -Acute re % High hematocrit n = 640 A 1.9 % Low hematocrit n = 53 B High hematocrit n = 113 High oxygen delivery Low oxygen delivery Group If we increase the pump flow and restore an adequate DO2,the ARF rate stays low; conversely, a low DO2 is associated to a high ARF even in presence of a high HCT C D Crit Care 2011

44

45

46 Outline CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what (probably) bl can do : ten golden rules 1. Limit hemodilution on CPB 0.25 AK KI rate (% with 95% CI) Nadir HCT on CPB (%)

47 2. Always stay at a DO2 > 270 ml/min/m2 3. Increase the DO2 by acting on pump flow, PaO2

48 4. Transfuse RBC based on SvO2 and O2ER, avoid inappropriate transfusions 5. Avoid hemolysis 6. Avoid hypotension 7. Do not exceed with cell-saving 8. UF, MUF, ZB-UF are not magic bullets

49 9. Hypothermia is not bad to the kidney, but rewarming may be. Rewarming phase is the most critical for DO2 10. Do not rely on pharmacological agents /fenoldopam, sodium bicarbonate, statines..

The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy

The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy Cindy Goodrich RN, MS, CCRN Content Description Sepsis is caused by widespread tissue injury and systemic inflammation resulting

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Septic Shock: Pharmacologic Agents for Hemodynamic Support Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Objectives Define septic shock and briefly review pathophysiology Outline receptor

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

Pediatric AKI and Application of Biomarkers

Pediatric AKI and Application of Biomarkers Pediatric AKI and Application of Biomarkers Arnold O. Beckman Conference Michael Zappitelli MD, MSc Most AKI is ATN and multifactorial Glomerular Tubular Vascular Interstitial Child AKI disease model Community

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

La valutazione dell emodinamica in corso di insufficienza renale acuta

La valutazione dell emodinamica in corso di insufficienza renale acuta U.O. Nefrologia, Dialisi, Ipertensione Policlinico S.Orsola-Malpighi Bologna - ITALY La valutazione dell emodinamica in corso di insufficienza renale acuta Elena Mancini, Antonio Santoro La Sindrome Cardio-Renale

More information

Nierfunctiemeting en follow-up van chronisch nierlijden

Nierfunctiemeting en follow-up van chronisch nierlijden Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated

More information

Acute Renal Failure. usually a consequence.

Acute Renal Failure. usually a consequence. Acute Renal Failure usually a consequence www.philippelefevre.com Definitions Pathogenisis Classification ICU Incidence/ Significance Treatments Prerenal Azotaemia Blood Pressure Cardiopulmonary Baroreceptors

More information

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:

More information

Diabetes and the Kidneys

Diabetes and the Kidneys Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease

More information

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality C. Tomas, MA Castel, E Roig, I. Vallejos, C. Plata, F. Pérez-Villa Cardiology Department,

More information

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali

More information

Improving the reporting of Medication Incidents. From Incident Reporting to Controls Assurance

Improving the reporting of Medication Incidents. From Incident Reporting to Controls Assurance Improving the reporting of Medication Incidents From Incident Reporting to Controls Assurance Quote Strive for perfection in everything you do. Take the best that exists and make it better. When it does

More information

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary

More information

STAGES OF SHOCK. IRREVERSIBLE SHOCK Heart deteriorates until it can no longer pump and death occurs.

STAGES OF SHOCK. IRREVERSIBLE SHOCK Heart deteriorates until it can no longer pump and death occurs. STAGES OF SHOCK SHOCK : A profound disturbance of circulation and metabolism, which leads to inadequate perfusion of all organs which are needed to maintain life. COMPENSATED NONPROGRESSIVE SHOCK 30 sec

More information

Medical Direction and Practices Board WHITE PAPER

Medical Direction and Practices Board WHITE PAPER Medical Direction and Practices Board WHITE PAPER Use of Pressors in Pre-Hospital Medicine: Proper Indication and State of the Science Regarding Proper Choice of Pressor BACKGROUND Shock is caused by a

More information

Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August 9, 2013

Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August 9, 2013 Stony Brook Medicine Severe Sepsis/Septic Shock Recognition and Treatment Protocols Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August

More information

Interpretation of Laboratory Values

Interpretation of Laboratory Values Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances

More information

VASOPRESSOR AGENTS IN SEPTIC SHOCK

VASOPRESSOR AGENTS IN SEPTIC SHOCK VASOPRESSOR AGENTS IN SEPTIC SHOCK Daniel De Backer Head Dept Intensive Care, CHIREC hospitals, Belgium Professor of Intensive Care, Université Libre de Bruxelles President European Society of Intensive

More information

HA Territory-wide PCI Audit 2003-05

HA Territory-wide PCI Audit 2003-05 HA Territory-wide PCI Audit 23-5 5 PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 26 Percutaneous Coronary Intervention Background HA AP target 2/3, coordinated by PCI Working

More information

Thoracoabdominal aortic aneurysm

Thoracoabdominal aortic aneurysm Thoracoabdominal aortic aneurysm Patient (1) - 69 PMH: 2013 - MVP, aortic root replacement with biological valve (Perimount) and subtotal aortic arch replacement Analysis for oppressive chest complaints

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

Eliminating Pressure Ulcers in Ascension Health

Eliminating Pressure Ulcers in Ascension Health Eliminating Pressure Ulcers in Ascension Health Cissy Shanks RN BSN CEN & Pam Kleinhelter RN MSN CNA-BC Nursing Managers St Vincent s Health System Jacksonville, Florida Objectives Participants will be

More information

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department Sohil Pothiawala FAMS (EM), MRCSEd (A&E), M.Med (EM), MBBS Consultant Dept. of Emergency Medicine Singapore General Hospital

More information

Update in Contrast Induced Nephropathy

Update in Contrast Induced Nephropathy Update in Contrast Induced Nephropathy Yves Pirson Service de Néphrologie, Clin. Univ. St-Luc - UCL A 76-year-old man with - type 2 diabetes - CKD (ser. creat.: 1.8 mg/dl; GFR: 32) presents with angina

More information

Three new/novel oral anticoagulants (NOAC) have been licensed in Ireland since 2008:

Three new/novel oral anticoagulants (NOAC) have been licensed in Ireland since 2008: Key Points to consider when prescribing NOACs Introduction Three new/novel oral anticoagulants (NOAC) have been licensed in Ireland since 2008: Dabigatran Etexilate (Pradaxa ) 75mg, 110mg, 150mg. Rivaroxaban

More information

Oxygen Therapy. Oxygen therapy quick guide V3 July 2012.

Oxygen Therapy. Oxygen therapy quick guide V3 July 2012. PRESENTATION Oxygen (O 2 ) is a gas provided in a compressed form in a cylinder. It is also available in a liquid form. It is fed via a regulator and flow meter to the patient by means of plastic tubing

More information

Sepsis: Identification and Treatment

Sepsis: Identification and Treatment Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge

More information

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h See EMR adult VTE prophylaxis CI order set Enoxaparin See service specific dosing Assess

More information

SE5h, Sepsis Education.pdf. Surviving Sepsis

SE5h, Sepsis Education.pdf. Surviving Sepsis Surviving Sepsis 1 Scope and Impact of the Problem: Severe sepsis is a major healthcare problem that affects millions of people around the world each year with an extremely high mortality rate of 30 to

More information

Vasopressors. Judith Hellman, M.D. Associate Professor Anesthesia and Perioperative Care University of California, San Francisco

Vasopressors. Judith Hellman, M.D. Associate Professor Anesthesia and Perioperative Care University of California, San Francisco Vasopressors Judith Hellman, M.D. Associate Professor Anesthesia and Perioperative Care University of California, San Francisco Overview Define shock states Review drugs commonly used to treat hypotension

More information

James F. Kravec, M.D., F.A.C.P

James F. Kravec, M.D., F.A.C.P James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice

More information

Advanced Clinical Decision Support & Acute Kidney Injury

Advanced Clinical Decision Support & Acute Kidney Injury Advanced Clinical Decision Support & Acute Kidney Injury Dr Jamie Coleman Senior Lecturer in Clinical Pharmacology and Honorary Consultant Physician eprescribing & CDS in Birmingham, UK Jamie Coleman 1

More information

NORTH WALES CRITICAL CARE NETWORK

NORTH WALES CRITICAL CARE NETWORK NORTH WALES CRITICAL CARE NETWORK LEVELS OF CRITICAL CARE FOR ADULT PATIENTS Throughout the work of the North Wales Critical Care Network reference to Levels of Care for the critically ill are frequently

More information

Decreasing Sepsis Mortality at the University of Colorado Hospital

Decreasing Sepsis Mortality at the University of Colorado Hospital Decreasing Sepsis Mortality at the University of Colorado Hospital Maureen Dzialo, RN, BSN - Nurse Manager, Cardiac Intensive Care Unit Olivia Kerveillant, RN Clinical Nurse III, Medical Intensive Care

More information

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation

More information

Nefropatia de Contraste

Nefropatia de Contraste Nefropatia de Contraste H. Luz Rodrigues Serviço de Nefrologia e Transplantação Instituto de Farmacologia e Neurociências Contrast-induced nephropathy Agenda Pathogenesis Clinical features Prevention Postulated

More information

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care Southern Derbyshire Shared Care Pathology Guidelines AKI guidelines for primary care Contents: FLOW DIAGRAM: MANAGEMENT OF PATIENTS WITH AKI DETECTED IN PRIMARY CARE...2 FLOW DIAGRAM: POST AKI MANAGEMENT

More information

AKI in Acute Dialysis Units outside ICU across Finland

AKI in Acute Dialysis Units outside ICU across Finland AKI in Acute Dialysis Units outside ICU across Finland Mikko Haapio, MD Consulting Nephrologist Helsinki University Central Hospital Department of Nephrology mikko.haapio@hus.fi FINNAKI-Nephro In conjunction

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND: STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention

More information

Antonio Colombo MD on behalf of the SECURITY Investigators

Antonio Colombo MD on behalf of the SECURITY Investigators Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy - The SECURITY Randomized Clinical Trial Antonio Colombo MD on behalf of the SECURITY

More information

Geriatric Cardiology: Challenges and Strategies

Geriatric Cardiology: Challenges and Strategies Geriatric Cardiology: Challenges and Strategies No financial disclosures Geriatrics -- No Specific Age 'you know it when you see it' Functional Status Polypharmacy Impaired Renal Function Diagnostic Testing:

More information

Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi

Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi What is EWS? After qualifying, junior doctors are expected to distinguish between the moderately sick patients who can be managed in the

More information

Absolute cardiovascular disease risk assessment

Absolute cardiovascular disease risk assessment Quick reference guide for health professionals Absolute cardiovascular disease risk assessment This quick reference guide is a summary of the key steps involved in assessing absolute cardiovascular risk

More information

Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I

Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Suffolk County Community College School of Nursing NUR 133 ADULT NURSING I Page # 1 Instructions for students: Case study # 1 For this lab, you are planning to provide care to the following client: CB

More information

Guideline for Microalbuminuria Screening

Guideline for Microalbuminuria Screening East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network

More information

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013 Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013 Family physician with Rivergrove Medical Clinic Practice in the north end since 1985 Medical Director of the Wellness

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

La prevenzione della nefropatia da contrasto nel paziente cardiologico. Carlo Guastoni U.O. Nefrologia Ospedale Civile di Legnano

La prevenzione della nefropatia da contrasto nel paziente cardiologico. Carlo Guastoni U.O. Nefrologia Ospedale Civile di Legnano La prevenzione della nefropatia da contrasto nel paziente cardiologico. Carlo Guastoni U.O. Nefrologia Ospedale Civile di Legnano CIN (CI-AKI) definition Both clinical studies and ESUR definition (Thomsen

More information

Optimal fluid therapy in 2013. Eric Hoste Department of Intensive Care Medicine Ghent University Hospital Ghent University

Optimal fluid therapy in 2013. Eric Hoste Department of Intensive Care Medicine Ghent University Hospital Ghent University Optimal fluid therapy in 2013 Eric Hoste Department of Intensive Care Medicine Ghent University Hospital Ghent University EGDT: fluids are good & prevent AKI Lin et al, Shock 2006 EGDT and AKI Prowle et

More information

Oxygen - update April 2009 OXG

Oxygen - update April 2009 OXG PRESENTATION Oxygen (O 2 ) is a gas provided in compressed form in a cylinder. It is also available in liquid form, in a system adapted for ambulance use. It is fed via a regulator and flow meter to the

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic

More information

Update on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new?

Update on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new? Update on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new? DVM, DACVA Objective: Update on the new Small animal guidelines for CPR and a discussion of the 2012 Reassessment Campaign on

More information

Anticoagulants in Atrial Fibrillation

Anticoagulants in Atrial Fibrillation Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Models of Chronic Kidney Disease Care and Initiation of Dialysis Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Early Crash Landings Talk Outline Pathways & Definitions Guideline recommendations

More information

240- PROBLEM SET INSERTION OF SWAN-GANZ SYSTEMIC VASCULAR RESISTANCE. Blood pressure = f(cardiac output and peripheral resistance)

240- PROBLEM SET INSERTION OF SWAN-GANZ SYSTEMIC VASCULAR RESISTANCE. Blood pressure = f(cardiac output and peripheral resistance) 240- PROBLEM SET INSERTION OF SWAN-GANZ 50 kg Pig Rt Jugular 0 cm Rt Atrium 10 cm Rt ventricle 15 cm Wedge 20-25 cm SYSTEMIC VASCULAR RESISTANCE Blood pressure = f(cardiac output and peripheral resistance)

More information

PREOPERATIVE CARDIAC RISK FOR NONCARDIAC SURGERY Review of 2014 ACC/AHA Guidelines and Implications for Clinical Care

PREOPERATIVE CARDIAC RISK FOR NONCARDIAC SURGERY Review of 2014 ACC/AHA Guidelines and Implications for Clinical Care PREOPERATIVE CARDIAC RISK FOR NONCARDIAC SURGERY Review of 2014 ACC/AHA Guidelines and Implications for Clinical Care Ronald L Walsh, D.O., MACOI, FACC ACOI Clinical Challenges in Inpatient Care March

More information

U.S. Food and Drug Administration

U.S. Food and Drug Administration U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.

More information

ESIM 2014 WHEN CHRONIC BECOMES ACUTE

ESIM 2014 WHEN CHRONIC BECOMES ACUTE ESIM 2014 WHEN CHRONIC BECOMES ACUTE Anna Salina, MD Pauls Stradins Clinical University Hospital Riga, Latvia 37 years old female, 50 kg, 150 cm Complaints Severe edema +8 kg Tiredness, dry cough Chills

More information

Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm

Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm CHAPTER 6 Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm JW Haveman, A Karliczek, ELG Verhoeven, IFJ Tielliu, R de Vos, JH Zwaveling, JJAM

More information

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156 introduction 152 < mortality in high- & low-risk patients 154 < predictors of mortality 156 < impact of anemia & dialysis therapy on mortality 158 < mortality in esrd patients with rare s 16 < expected

More information

Telemedicine Resuscitation & Arrest Trials (TreAT)

Telemedicine Resuscitation & Arrest Trials (TreAT) Telemedicine Resuscitation & Arrest Trials (TreAT) Telemedicine within the ED for treating Severe Sepsis: A Hub and Spoke Telemedicine pilot SUMR Intern: Karole Collier Mentor: Dr. Brendan Carr & Dr. Anish

More information

Inpatient Code Sepsis March Update. Sarah Prebil

Inpatient Code Sepsis March Update. Sarah Prebil Inpatient Code Sepsis March Update Sarah Prebil 3 hour bundle Time is life Kumar et al. Crit Care Med 2006; 34:1589-1596 But Sarah, why are you harassing us about sepsis? Pilot Results 10 Code Sepsis pabents

More information

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options?

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options? Patient decision aid Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options? http://guidance.nice.org.uk/cg180/patientdecisionaid/pdf/english Published: June 2014 About

More information

Grading of acute kidney injury (2013)

Grading of acute kidney injury (2013) Acute kidney disease represents a spectrum of disease associated with a sudden onset of renal parenchymal injury most typically characterized by generalized failure of the kidneys to meet the excretory,

More information

Renal Disease in Type 2 Diabetes Mellitus

Renal Disease in Type 2 Diabetes Mellitus Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman

More information

Dehydration & Overhydration. Waseem Jerjes

Dehydration & Overhydration. Waseem Jerjes Dehydration & Overhydration Waseem Jerjes Dehydration 3 Major Types Isotonic - Fluid has the same osmolarity as plasma Hypotonic -Fluid has fewer solutes than plasma Hypertonic-Fluid has more solutes than

More information

Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology*

Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology* Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology* =Abstracts= Registry committee of Korean Society of Nephrology

More information

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION

More information

Advantages and disadvantages of CRRT in ARF patients. Norbert Lameire Renal Division University Hospital Ghent, Belgium

Advantages and disadvantages of CRRT in ARF patients. Norbert Lameire Renal Division University Hospital Ghent, Belgium Advantages and disadvantages of CRRT in ARF patients Norbert Lameire Renal Division University Hospital Ghent, Belgium Alexandria, 17/2/2005 Indications for RRT in critically ill ARF patients Renal Replacement

More information

Preoperative Laboratory and Diagnostic Studies

Preoperative Laboratory and Diagnostic Studies Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no

More information

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis Michael A. Blazing Outline The coming crush A practical approach to clinical risk assessment Classic approach to

More information

How To Know If Low Protein Diet Is Beneficial For Kidney Health

How To Know If Low Protein Diet Is Beneficial For Kidney Health Protein Intake and Diabetic Kidney Disease Robert C. Stanton Joslin Diabetes Center 1/Serum Creatinine Plot Low Protein Protects in Renal Ablation Model 24% Protein Diet 6% Protein Diet Right Nephrectomy

More information

Estimated GFR Based on Creatinine and Cystatin C

Estimated GFR Based on Creatinine and Cystatin C Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,

More information

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical

More information

Acute on Chronic Liver Failure: Current Concepts. Disclosures

Acute on Chronic Liver Failure: Current Concepts. Disclosures Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures

More information

Atrial Fibrillation An update on diagnosis and management

Atrial Fibrillation An update on diagnosis and management Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.

More information

Package nephro. February 23, 2015

Package nephro. February 23, 2015 Type Pack Title Biostatistics Utilities for Nephrology Version 1.1 Date 2015-01-31 Author Pack nephro February 23, 2015 Maintainer Set of functions to estimate the Glomerular

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris Pros and cons of registers Prospective randomised trials constitute the cornerstone of "evidence-based" medicine, and they therefore

More information

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic THE GEORGE INSTITUTE FOR GLOBAL HEALTH Antiocoagulation in diabetes and CKD Vlado Perkovic Executive Director, George Institute Australia Professor of Medicine, University of Sydney Affiliated with the

More information

Continuous Renal Replacement Therapy. Jai Radhakrishnan, MD, MS

Continuous Renal Replacement Therapy. Jai Radhakrishnan, MD, MS Continuous Renal Replacement Therapy Jai Radhakrishnan, MD, MS History of the CRRT program 1988 Open heart program Active transplant program Deep dissatisfaction with peritoneal dialysis in hemodynamically

More information

Replacement post-filter (ml/hr) Blood flow (ml/min) Dialysate (ml/hr) Weight (kg)

Replacement post-filter (ml/hr) Blood flow (ml/min) Dialysate (ml/hr) Weight (kg) 404FM.1 CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) USING CITRATE Target Audience: Hospital only ICU (Based on Gambro and Kalmar Hospital protocols) CRRT using regional citrate anticoagulation This is

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

Treatment of cardiogenic shock

Treatment of cardiogenic shock ACUTE HEART FAILURE AND COMORBIDITY IN THE ELDERLY Treatment of cardiogenic shock Christian J. Wiedermann, M.D., F.A.C.P. Associate Professor of Internal Medicine, Medical University of Innsbruck, Austria

More information

Surgery in the Patient with Renal Dysfunction

Surgery in the Patient with Renal Dysfunction Surgery in the Patient with Renal Dysfunction Dean R. Jones, MD, FRCPC a,h.t.lee,md, PhD b, * KEYWORDS Chronic kidney disease Acute kidney injury Renal failure Renal protection Preoperative evaluation

More information

Severity scores in ICU

Severity scores in ICU Severity scores in ICU DM seminar Dr.Vamsi Krishna Mootha Dept of Pulmonary medicine, PGIMER Introduction Severity of illness scoring systems are developed to evaluate delivery of care and provide prediction

More information

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,

More information

Safe Zone: CV PIP < 26; HFOV: MAP < 16; HFJV: MAP < 16 Dopamine infusion up to 20 mcg/kg/min Epinephrine infusion up to 0.1 mcg /kg/min.

Safe Zone: CV PIP < 26; HFOV: MAP < 16; HFJV: MAP < 16 Dopamine infusion up to 20 mcg/kg/min Epinephrine infusion up to 0.1 mcg /kg/min. Congenital Diaphragmatic Hernia: Management Guidelines 5-2006 Issued By: Division of Neonatology Reviewed: Effective Date: Categories: Chronicity Document Congenital Diaphragmatic Hernia: Management Guidelines

More information

ΠΟΙΟ ΑΝΤΙΠΗΚΤΙΚΟ ΓΙΑ ΤΟΝ ΑΣΘΕΝΗ ΜΟΥ? ΚΛΙΝΙΚΑ ΠΑΡΑΔΕΙΓΜΑΤΑ. Σωκράτης Παστρωμάς Καρδιολόγος Νοσοκομείο Ερρίκος Ντυνάν

ΠΟΙΟ ΑΝΤΙΠΗΚΤΙΚΟ ΓΙΑ ΤΟΝ ΑΣΘΕΝΗ ΜΟΥ? ΚΛΙΝΙΚΑ ΠΑΡΑΔΕΙΓΜΑΤΑ. Σωκράτης Παστρωμάς Καρδιολόγος Νοσοκομείο Ερρίκος Ντυνάν ΠΟΙΟ ΑΝΤΙΠΗΚΤΙΚΟ ΓΙΑ ΤΟΝ ΑΣΘΕΝΗ ΜΟΥ? ΚΛΙΝΙΚΑ ΠΑΡΑΔΕΙΓΜΑΤΑ Σωκράτης Παστρωμάς Καρδιολόγος Νοσοκομείο Ερρίκος Ντυνάν The AF epidemic Mayo Clinic data (assuming a continued increase in the AF incidence) Mayo

More information

06 Validation of risk prediction model

06 Validation of risk prediction model HA Territory-wide PCI Audit 2003-06 06 Validation of risk prediction model PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 2007 Background Participants: All HA hospitals via

More information

IMPAIRED BLOOD-GAS EXCHANGE. Intraoperative blood gas analysis

IMPAIRED BLOOD-GAS EXCHANGE. Intraoperative blood gas analysis IMPAIRED BLOOD-GAS EXCHANGE Intraoperative blood gas analysis When do you perform BGA Intraoperatively? Informe actual NEVER Routine:Thoracic Thoracic, Cardiac,Neurosurgery Emergency situation Drop in

More information

David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010

David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010 David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010 Objectives At the end of the talk, the participants will be able to: 1. Identify the increasing prevalence of type 2 diabetes

More information

Coding to be more efficient and accurate

Coding to be more efficient and accurate Why we need to code well! Coding to be more efficient and accurate Diabetes without Complication Diabetes with opthamologic or unspecified complication Diabetes with acute complication $1833 $2931 $3836

More information

Acid-Base Balance and the Anion Gap

Acid-Base Balance and the Anion Gap Acid-Base Balance and the Anion Gap 1. The body strives for electrical neutrality. a. Cations = Anions b. One of the cations is very special, H +, and its concentration is monitored and regulated very

More information

1/12/2016. What s in a name? What s in a name? NO.Anti-Coagulation. DOACs in clinical practice. Practical aspects of using

1/12/2016. What s in a name? What s in a name? NO.Anti-Coagulation. DOACs in clinical practice. Practical aspects of using What s in a name? Practical aspects of using DOACs (Direct Oral Anticoagulants) James L. Sebastian, MD, MACP Professor of Medicine (GIM) Medical College of Wisconsin February 5, 2016 DOAC NOAC NOAC ODI

More information